Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
103P Rate of BRCA1/2 pathogenic variants according to family and personal history of cancer in a large cohort of triple-negative breast cancer (TNBC) patients (pts) younger than 60 years of ageZovato, S. ; Griguolo, G. ; Agata, S. ; Tognazzo, S. ; Dieci, M.V. ; Matricardi, L. ; Crivellari, G. ; Miglietta, F. ; Alducci, E. ; Moserle, L. ; Conte, P.F. ; Montagna, M. ; Guarneri, V.Annals of oncology, 2021-09, Vol.32, p.S400-S401 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
2 |
Material Type: Artigo
|
105P A model of workflow for radiomics signature of stage III non-small cell lung cancer (NSCLC) patients (pts)Ferro, A. ; Pasello, G. ; Scagliori, E. ; Caumo, F. ; Costa, M. ; Frega, S. ; Sepulcri, M. ; Bonanno, L. ; Rea, F. ; Guarneri, V. ; Gennaro, G.Annals of oncology, 2022-04, Vol.33, p.S79-S80 [Periódico revisado por pares]Texto completo disponível |
|
3 |
Material Type: Artigo
|
1081O_PRPROFESSIONAL BURNOUT IN EUROPEAN YOUNG ONCOLOGISTS: A EUROPEAN SURVEY CONDUCTED BY THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) YOUNG ONCOLOGISTS COMMITTEEBanerjee, S ; Califano, R ; Corral, J ; De Azambuja, E ; De Mattos-Arruda, L ; Guarneri, V ; Hutka, M ; Jordan, K ; Martinelli, E ; Mountzios, G ; Ozturk, M.A ; Petrova, M ; Postel-Vinay, S ; Preusser, M ; Qvortrup, C ; Strijbos, M ; Volkov, N.M ; Olmos, DAnnals of oncology, 2014-09, Vol.25 (suppl_4) [Periódico revisado por pares]Oxford University PressTexto completo disponível |
|
4 |
Material Type: Artigo
|
1157P Diagnostic therapeutic pathway (DTP) of early stage non-small cell lung cancer (eNSCLC): A real-world focus on EGFR status detection in resected patients (pts)Pasello, G. ; Lorenzi, M. ; Pretelli, G. ; Pezzuto, F. ; Comacchio, G. ; Buja, A. ; Bonanno, L. ; Guarneri, V. ; Conte, P.F. ; Rea, F. ; Calabrese, F.Annals of oncology, 2021-09, Vol.32, p.S933-S933 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
5 |
Material Type: Artigo
|
119P Evolution of the management of stage III non-small cell lung cancer (NSCLC): A single-center real-world scenario over 10 yearsFerro, A. ; Sepulcri, M. ; Schiavon, M. ; Scagliori, E. ; Gennaro, G. ; Costa, M. ; Bonanno, L. ; Frega, S. ; Dal Maso, A. ; Calabrese, F. ; Rea, F. ; Caumo, F. ; Guarneri, V. ; Pasello, G.Annals of oncology, 2022-04, Vol.33, p.S87 [Periódico revisado por pares]Texto completo disponível |
|
6 |
Material Type: Artigo
|
1221P Surgically resected superior sulcus (SS) non-small cell lung cancer (NSCLC) after induction chemo (C)- and radiotherapy (R): A focus on the immune microenvironment (IM)Pavan, A. ; Fortarezza, F. ; Pezzuto, F. ; Polverosi, R. ; Evangelista, L. ; Frega, S. ; Bonanno, L. ; Guarneri, V. ; Rea, F. ; Conte, P.F. ; Calabrese, F. ; Pasello, G.Annals of oncology, 2020-09, Vol.31, p.S797-S797 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
129P Association of clinico-pathological markers with longitudinal liquid biopsy (LB) results predicts outcome in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs)Bonanno, L. ; Zulato, E. ; Del Bianco, P. ; Boscolo Bragadin, A. ; Attili, I. ; Pavan, A. ; Nardo, G. ; Dal Maso, A. ; Ferro, A. ; Frega, S. ; Pasello, G. ; M. Fassan ; Calabrese, F. ; Guarneri, V. ; Indraccolo, S.Annals of oncology, 2022-09, Vol.33, p.S596 [Periódico revisado por pares]Texto completo disponível |
|
8 |
Material Type: Artigo
|
129P Integration of gene expression and tumor-infiltrating lymphocytes (TILs) to predict pCR after neoadjuvant chemotherapy and nivolumab for patients with luminal B-like breast cancer in the phase II GIADA trialDieci, M.V. ; Griguolo, G. ; Bisagni, G. ; Musolino, A. ; Spazzapan, S. ; Moretti, G. ; Schiavi, F. ; Pinato, C. ; Vernaci, G.M. ; Giarratano, T. ; Urso, L. ; Tosi, A. ; Magni, G. ; Lo Mele, M. ; De Salvo, G.L. ; Rosato, A. ; Guarneri, V. ; Conte, P.F.Annals of oncology, 2021-09, Vol.32, p.S414-S414 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
9 |
Material Type: Artigo
|
1398P Real-life progression (PD) pattern of EGFR mutant advanced non-small cell lung cancer (aNSCLC) patients (pts) receiving systemic therapy after first- or second-generation tyrosine kinase inhibitor (1-2 gen TKI)Maso, A. Dal ; Ferro, A. ; Lorenzi, M. ; Polo, V. ; Scattolin, D. ; Del Conte, A. ; Scoccia, E. ; Frega, S. ; Bonanno, L. ; Indraccolo, S. ; Calabrese, F. ; Guarneri, V. ; Conte, P.F. ; Pasello, G.Annals of oncology, 2020-09, Vol.31, p.S886-S886 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
10 |
Material Type: Artigo
|
140MO HER2DX genomic test in HER2-positive/hormone receptor-positive (HER2+/HR+) breast cancer (BC) treated with neoadjuvant trastuzumab (T) and pertuzumab (P): A correlative analysis from the PerELISA trialGuarneri, V. ; Dieci, M.V. ; Griguolo, G. ; Pare Brunet, L. ; Marin, M. ; Miglietta, F. ; Bottosso, M. ; Giorgi, C.A. ; Blasco, P. ; Castillo, O. ; Galván, P. ; Jares, P. ; Puig-butille, J.A. ; Vivancos, A. ; Villagrasa Gonzalez, P. ; Parker, J. ; Perou, C.M. ; Conte, P.F. ; Prat, A.Annals of oncology, 2022-09, Vol.33, p.S603 [Periódico revisado por pares]Texto completo disponível |